| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/20/1979 | US4140756 Film-coated matrix core tablet |
| 02/20/1979 | US4140755 Multilayer antacids |
| 02/20/1979 | US4140537 Low immunogenic response, free of telopeptides, biological and medical application |
| 02/13/1979 | US4139630 Nonionic surface active anti-viral agents |
| 02/13/1979 | US4139627 3-piperidino-p-alkoxypropiophenones in candy base, acid stabilizers |
| 02/13/1979 | US4139607 Aerosol propellant for personal products |
| 02/07/1979 | EP0000667A1 Intravascularly-administrable, magnetically-localizable biodegradable carrier and process for its preparation |
| 02/07/1979 | EP0000507A1 Process for the production of hydrogels in the form of spherically shaped beads with larger diameters |
| 02/06/1979 | US4138565 Hydrogenated ergopeptide alkaloid in an alcohol |
| 02/06/1979 | US4138475 Sustained release pharmaceutical composition |
| 02/06/1979 | US4138362 Formation of microcapsules by interfacial cross-linking, microcapsules produced, and microcapsular dispersion |
| 02/06/1979 | US4138344 Erodible agent releasing device comprising poly(orthoesters) and poly(orthocarbonates) |
| 02/06/1979 | US4138013 Enteric capsules |
| 02/06/1979 | CA1047930A1 Stable topical anesthetic compositions |
| 02/06/1979 | CA1047928A1 Effervescent enteric coated l-dopa formulation and method of using the same |
| 02/06/1979 | CA1047924A1 Powdered emulsion product and method of production |
| 02/06/1979 | CA1047921A1 Liposomes used as adjuvants in vaccines |
| 02/06/1979 | CA1047874A1 Osmotically driven dispenser and process for making same |
| 01/30/1979 | US4137394 Removal at rate equal to that of crystal growth |
| 01/30/1979 | US4137301 Method of inhibiting skin irritation |
| 01/30/1979 | US4137300 Sustained action dosage forms |
| 01/30/1979 | US4137200 Polyurethanes |
| 01/30/1979 | CA1047406A1 Enzyme-containing denture cleanser tablet |
| 01/30/1979 | CA1047404A1 Stable preparation of water-soluble salts of dehydroeplandrosterone sulfate for parenteral administration |
| 01/30/1979 | CA1047403A1 Process for making a monolithic drug delivery device |
| 01/30/1979 | CA1047402A1 Intra-uterine device |
| 01/24/1979 | EP0000353A2 Bicyclic thiadiaza compounds, process and intermediates for their preparation, and medicaments containing these compounds or the intermediates |
| 01/23/1979 | US4136250 Crosslinked, addition monomer or polymer |
| 01/23/1979 | US4136178 Locust bean gum therapeutic compositions |
| 01/23/1979 | US4136177 Xanthan gum therapeutic compositions |
| 01/23/1979 | US4136173 Mixed xanthan gum and locust beam gum therapeutic compositions |
| 01/23/1979 | US4136172 Fungicidal composition and method of use |
| 01/23/1979 | US4136162 Easily cut unit dosage for enteral or topical administration |
| 01/23/1979 | US4136145 Medicament carriers in the form of film having active substance incorporated therein |
| 01/23/1979 | US4135935 Sintered composite material, a process of making same, and a method of using same |
| 01/23/1979 | US4135514 Osmotic releasing system for administering ophthalmic drug to eye of animal |
| 01/23/1979 | CA1046939A1 Prolonged release drug form for the treatment of bovine mastitis |
| 01/23/1979 | CA1046938A1 Griseofulvin dosage forms |
| 01/23/1979 | CA1046937A1 Permanent suspension pharmaceutical dosage forms |
| 01/16/1979 | US4134943 Mixing with solvent, freezing, evaporation |
| 01/16/1979 | US4134725 Process for the production of granules |
| 01/16/1979 | US4134538 Process and apparatus for identification of objects |
| 01/16/1979 | CA1046410A1 Cardiotonic composition |
| 01/16/1979 | CA1046408A1 Sustained release dispensing device and method |
| 01/16/1979 | CA1046405A1 Human sterilization |
| 01/11/1979 | WO1979000014A1 Biologically compatible tampon sponge |
| 01/10/1979 | EP0000291A1 A pharmaceutical composition for tropical diseases |
| 01/10/1979 | EP0000276A1 A novel crystalline form of benoxaprofen, methods of preparation thereof and pharmaceutical formulations containing said novel form |
| 01/10/1979 | EP0000133A1 Pharmaceutical preparations containing sulfated polysaccharides or polymers and zinc ions for topical application in virus infections. |
| 01/09/1979 | US4133874 Lipid encapsulated hemoglobin cells |
| 01/09/1979 | CA1046055A1 Modified ethyl cellulose |
| 01/09/1979 | CA1045977A1 Biodegradable, implantable drug delivery device, and process for preparing and using the same |
| 01/09/1979 | CA1045976A1 Liquid membrane encapsulated medicinals and uses thereof |
| 01/09/1979 | CA1045975A1 Enzyme degradable medicament carriers |
| 01/09/1979 | CA1045974A1 Oil-free pharmaceutical cream |
| 01/02/1979 | US4132781 Method for treatment of acne |
| 01/02/1979 | US4132777 Natamycin and citric acid |
| 01/02/1979 | US4132760 Hemihydrate type phosphoric acid process using reduced pressure |
| 01/02/1979 | US4132753 Process for preparing oral sustained release granules |
| 01/02/1979 | CA1045549A1 Injectable amoxycillin-dispersing agent compositions |
| 01/02/1979 | CA1045547A1 Capsule, especially for medicaments |
| 12/26/1978 | US4131651 Hydroxyalkyl cellulose and polyvinyl alcohol |
| 12/26/1978 | US4131648 Polymeric materials |
| 12/26/1978 | CA1045114A1 .gamma.-CRYSTALLINE FORM OF SODIUM 7-(D-.alpha.-FORMYLOXY-.alpha.-PHENYLACETAMIDO)-3-(1-METHYL-1H-TETRAZOL-5-YLTHIOMETHYL)-3-CEPHEM-4-CARBOXYLATE |
| 12/26/1978 | CA1045034A1 Veterinary treatment |
| 12/26/1978 | CA1045033A1 Self-supporting packs or capsules for wrapping drugs |
| 12/26/1978 | CA1045032A1 Antihemophilic factor |
| 12/21/1978 | WO1978000011A1 Form of implant medicament and preparation process |
| 12/19/1978 | US4130651 Anthelmintic |
| 12/19/1978 | US4130639 Absorbable pharmaceutical compositions based on isomorphic copolyoxalates |
| 12/19/1978 | US4130566 Process for producing 5-carboxy-2-acetylthiophene |
| 12/19/1978 | US4130558 Process for preparation of alkali metal salts of ampicillin |
| 12/12/1978 | US4129666 Method of providing pellets with a water insoluble coating using a melt |
| 12/12/1978 | US4129649 Process for producing easily absorbable amorphous steryl glucoside monopalmitates and preparations thereof |
| 12/12/1978 | CA1044140A1 Composition containing e-type prostaglandin-like compound |
| 12/07/1978 | WO1978000005A1 Magnetic polymer particles |
| 12/05/1978 | US4128632 Solubilization of Rafoxanide |
| 12/05/1978 | US4128445 Manufacture of pharmaceutical unit dosage forms |
| 12/05/1978 | US4128444 Manufacture of pharmaceutical unit dosage forms |
| 12/05/1978 | CA1043704A1 External drug delivery system |
| 11/28/1978 | US4127663 Thiazole derivatives to treat inflammation |
| 11/28/1978 | US4127650 Medicinal simethicone containing composition and its method of production |
| 11/28/1978 | US4127645 Effervescent tablet and method |
| 11/28/1978 | US4127622 Process for the preparation of hollow particulates |
| 11/28/1978 | US4127127 Therapeutic systems made from certain segmented copolyesters |
| 11/28/1978 | CA1043261A1 Cephalosporin-type antibiotic composition |
| 11/28/1978 | CA1043260A1 Water soluble lipophilic liquid fatty acid salts comprising therapeutic agents having a tertiary nitrogen capable of being protonated |
| 11/28/1978 | CA1043259A1 Medicament preparations and vehicles therefor |
| 11/28/1978 | CA1043258A1 Vitamin compositions |
| 11/28/1978 | CA1043240A1 Tagging medicaments with biodegradable microparticles to permit retrospective identification |
| 11/21/1978 | US4126681 Monoolein, a diol, an alcohol |
| 11/21/1978 | US4126672 Sustained release pharmaceutical capsules |
| 11/21/1978 | US4126503 Manufacture of pharmaceutical dosage forms |
| 11/21/1978 | US4126502 Manufacture of pharmaceutical dosage forms |
| 11/21/1978 | CA1042878A1 Method for preparing low-substituted cellulose ethers |
| 11/21/1978 | CA1042799A1 Perfluorocyclocarbons as gas transport agents in animals |
| 11/21/1978 | CA1042798A1 Composition having local anesthetic effect |
| 11/21/1978 | CA1042797A1 Aqueous rafoxanide formulations |
| 11/14/1978 | US4125603 Stabilized water-in-oil emulsions and compositions |
| 11/14/1978 | CA1042345A1 Oxygen-transferable emulsion |